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Abstract 
Purpose: The skin acts as the first line of defence against the invasion of microorganisms. Damage to 
the skin such as abrasion, bruises and trauma will expose underlying tissue to bacterial infection. Minor 
skin infections can be easily treated with topical antibacterial medication that is available over the 
counter or by prescription. On the other hand, serious bacterial skin infections can be life-threatening 
and may require complex interventions such as medical or surgical methods to cure the disease. The 
treatments given have to be assessed according to the presentation, aetiology, chronicity of the wound 
(depth and size) and/or skin lesions. For skin bacterial infection, topical route of administration is 
preferred over systemic administration due to the delivery of a higher concentration of medication for the 
former into the desired area. It is also less likely to cause systemic side effects, toxicity, and bacterial 
resistance. There is ongoing controversy and debate regarding the likelihood of developing bacterial 
resistance with the usage of topical antibiotics as an antibacterial. This could be due to inappropriate 
antibiotic use resulting from self-medication, over the counter availability, prescribing on demand and a 
lack of regulatory control.  
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The skin undoubtedly is the first line of defence 
against a broad range of bacterial. When the skin 
integrity is breached accidentally or purposely, its 
natural defences will thus be weakened and 
topical medication may be prescribed [1]. A 
topical medication refers to medication that is 
applied to body or tissue surfaces such as skin 
and conjunctiva [2]. Topical antibacterial drugs 
are commonly dispensed items by community 
pharmacists specifically for topical bacterial 
infection. Its role is to either kill or inhibit the 
growth of microorganism and can be used for 
both prophylaxis as well as treatment of 
superficial infection [3,4]. Topical antibacterial 
drugs are currently available in many forms such 
as gels, creams, ointments, sprays and liquids 
[2-4]. They either contain a single antibiotic 
ingredient or are in combination with other 
antibiotics or corticosteroids. Community 
pharmacy have a variety of topical antibacterial 
agents which are available for potential use in; 
acne vulgaris, pyoderma including impetigo, 
folliculitis, rosacea, infected eczema, secondarily 
infected traumatic skin lesions, prevention of 
infection in minor cut or burn, eyes and ear 
infection [5].  
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Nowadays, most people seek advices in 
managing their minor ailments from community 
pharmacists rather than seeking consultation 
from general practitioners (GP) [5].  This is 
supported by the data revealing that more people 
with skin infections (21.5 vs 20.5 %) and acne 
(6.6 vs 2.9 %) had purchased over-the-counter 
(OTC) products from pharmacy rather than 
visiting general practitioners. A survey also 
revealed that the public usually sought advice 
from community pharmacists for diseases 
include topical bacterial infection such as acne, 
eczema/dermatitis and impetigo [5-7]. In short, 
as the multidrug resistance incidence spreads 
globally and pose threat to our society, extensive 
international initiatives will be essential to curb its 
consequences. Meanwhile, the responsible use 
of topical antibiotic should be practiced especially 
among the primary healthcare settings where 
their main role is to make sure that the health 
services are accessible by the public. 
 
Nature of bacterial infections and topical 
antibacterials 
 
The advantages of topical route application as 
compared to systemic administration include the 
decreased risk of systemic side effects and even 
toxicity, reduced the possibility to elicit bacterial 
resistance, and the application of high 
concentration of antibacterial agent at the site of 
infection which will increase the effectiveness of 
the treatment [1]. Generally, skin infections are 
caused by many different types of bacteria. Most 
infections are due to gram-positive microbes 
such as Staphylococcus aureus, Enterococcus 
faecalis, Streptococcus viridans and so on. 
However, gram-negative bacteria infections can 
also occur. Examples of common gram-negative 
bacteria are: Escherichia coli, Haemophilus 
influenza, Clostridium species, Mycobacterium 
species, Pseudomonas species, and other 
anaerobes [1]. The use of antibiotics is very 
crucial, for instance; use the topical antibacterial 
agent only when a clear medical indication has 
been confirmed and as long as necessary to 
achieve the desired effect, use preferably 
combination therapy that minimizes the risk of 
bacteria resistance, and better use alternatives 
other than antibiotics when possible [8]. 
 
Condition and availability of topical 
antibacterial 
 
Nowadays, the production of countless topical 
over-the-counter topical antibiotic products have 
provided benefits to public health by reducing 
bacterial load on skin. The term topical 
antibacterial usually refers to both antimicrobial 
and antiseptic agents [9]. While the use of topical 
antibacterial is very common however, 
emergence of antibacterial resistance incidences 
had raised the concern worldwide. A steady 
supply of new antibiotics in the past that is 
effective against continuously emerging resistant 
strains adequately addressed resistance 
concerns [10]. However, nowadays, the 
combinations of different types of antibacterial 
not only enable bacteria to develop single 
resistance, but also multiple resistances. In 
alarming contrast to the past, today’s 
antibacterial research and development pipelines 
are nearly dry due to the rising resistance in 
conjunction with a lack of antibacterial innovation 
[10]. 
 
Topical antibacterial drugs are one of over-the-
counter (OTC) medications which is also known 
as self-medication products [11]. Common 
topical antibiotics that can be found in OTC are 
bacitracin, neomycin, fusidic acid, clindamycin, 
mupirocin, gentamicin, erythromycin, polymyxin 
B and chloramphenicol [12,13]. These topical 
antibiotics are available as sole agent as well as 
in combination with other topical antibiotics or 
with topical corticosteroids [12,14].  
 
Nowadays, community pharmacists are seen as 
first-line healthcare professionals for 
consultations [15,16]. Several studies stated that 
role of community pharmacists in the 
management of dermatological problems has 
increased dramatically over the decades [13,14]. 
Thus, the knowledge of community pharmacists 
in skin diseases is very vital [13,17]. Since topical 
antibacterial drugs are OTC medications, 
community pharmacists inevitably play a crucial 
role in dispensing, advising and counselling of 




Usage of topical antibacterial drugs 
 
There is lack of study on the perception and 
experiences of community pharmacists on the 
usage of topical antibacterial in community 
pharmacy settings. However, there are several 
surveys conducted worldwide on the use of 
combination topical antibacterial drugs by various 
healthcare sectors. For instance, National 
Ambulatory Medical Care Survey (NAMCS) in 
United States reported that combination of 
topical antibiotics products such as 
polymyxin/bacitracin, and neomycin/ polymyxin/ 
bacitracin are commonly used by all physicians 
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whereby they appeared to be the top 20 list of 
over-the-counter products used [11].  
 
Besides, Tucker’s study stated that community 
pharmacists felt comfortable in dispensing topical 
antibiotics. They wished to have topical 
antibiotic-steroid combination and topical 
antibiotics available as non-prescription/over-the-
counter products. Moreover, topical antibiotic-
steroid combination was also widely used in 
United Kingdom because evidence has shown 
that such combination products are more 
effective in the management of infected eczema. 
Nonetheless, it is also believed that popular 
usage of topical antibiotic-steroid combination 
products also influences pharmacists’ belief that 
this combination was generally more effective in 
treating skin diseases [14]. Another observational 
study by Davis et al, found that the sales of 
topical chloramphenicol increased to 47.8 % from 
year 2005 to 2007 after this topical antibiotic was 
made available over-the-counter [19].  
 
Dispensing of topical antibacterial drugs in 
community pharmacy 
 
Topical antibacterial drug is one of the over-the-
counter medications in which patient can obtain 
conveniently from community or retail 
pharmacies without a doctor’s prescription [11, 
18]. This means that patients can use topical 
antibacterial drugs for self-medication in treating 
topical infections [18]. Community pharmacists 
as the primary source for OTC medications 
counselling should obtain patients’ information 
which is critical to the case presented, then 
provide all necessary information and advice on 
medication, as well as assisting patient in 
choosing an appropriate treatment regimen to 
promote safe and effective use of medication 
[16,18,20].  Nonetheless, Wabe’s research 
reported that community pharmacists often failed 
in obtaining vital clinical information from the 
patients and there was little knowledge on drug 
usage [20]. This is supported by another study 
carried out in Portugal, whereby it mentioned that 
community pharmacists normally counselled 
patients on the standard dosage of antibiotic as 
they did not know the severity of infections 
though correct dosage depends upon the 
severity [15]. 
 
On the other hand, two studies have proposed 
that when community pharmacist  deal with 
dermatological problems, they would refer to 
published journal articles, followed by reference 
books, while media (television or radio) and 
wholesaler are less likely to influence 
pharmacists in the treatment of skin problems 
[17,20]. Besides, Wabe’s study stated that most 
of the community pharmacists would refer to 
patient’s information leaflets and books, but this 
was not recommended as it contained 
manipulated information which may cause bias 
[20]. The guidelines for selection of appropriate 
topical antibacterial is provided in Table 1. 
 
Factors affecting dispensing OTC products 
by community pharmacists 
 
To date, there are not many studies on the 
factors influencing the dispensing of topical 
antibacterial drugs by community pharmacists. 
However, as mentioned previously, topical 
antibacterial drug is one of the common over the 
counter (OTC) products, several studies did 
reflect on the factors affecting the selection of 
OTC products by community pharmacists. For 
instance, a study carried out in Northern Ireland 
revealed that medications safety was the main 
considerations in selecting an OTC product. 
However, patient product and professional 
factors were also involved in the decision making 
[33]. Apart from this, a study in Northeast Ohio 
showed that the main sources of information that 
usually influence community pharmacists 
selection of OTC products for dermatology 
conditions was pharmacy journals, followed by 
internet based sources and pharmacy settings 
with 62, 24 and 8 %, respectively [21]. 
 
 
           Table 1: Guidelines for selection of appropriate topical antibacterial [39] 
 
Skin type Treatment vehicle Comment 
Sensitive/dry 
skin 
Cream Non-irritating, non-drying 
Oily skin Gel 
 
Drying effect: certain kinds of cosmetics may not 
adhere to gel: may cause burning irritation 
Solutions Mainly used with topical antibiotics 
Any type Lotion Spread well over hairy areas: contains propylene 
glycol, which has burning/drying effects 
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Topical antibacterial drug resistance 
 
There are evidences showing the increase rates 
of antibacterial resistances from the use of 
topical antibiotic formulations. For instance, a 
study in United Kingdom (UK) showed that the 
number of patients carrying strains of Propioni 
bacterium resistant to clindamycin, erythromycin 
as well as tetracycline increased almost two folds 
within six years (1991 – 1997) and the resistance 
rates are as high as 55.5 % in year 2000. Among 
the three topical antibiotics mentioned, 
resistance to erythromycin was more common 
and it was found to be cross-resistant with 
clindamycin. Resistant to tetracycline on the 
other hand only increased a little over the time 
[22]. Besides that, fusidic acid also showed an 
increased resistance rates from 4.6 to 12.4 % 
from year 1994 to year 1997 in Western Australia 
while in New Zealand, the resistance rates 
increased from 2.4 to 17 % from year 1982 to 
year 1999 [23,24].  Moreover, mupirocin which is 
commonly used in acne treatment also showed 
to be having increased resistance rates 
especially to the S. aureus strains [25].  
 
All these studies demonstrate that antibiotic 
resistance cases should not be overlooked 
during the consideration of topical antibacterial 
drugs usages especially most of the topical 
antibiotics which are available over the counter 
nowadays. In fact, pharmacists play an important 
role to prevent inappropriate use of over the 
counter topical antibiotics preparations [22-26]. 
 
Increase of bacterial resistance rate 
 
Several studies have found that there was 
increasing resistance rate to mupirocin, fusidic 
acid, clindamycin, erythromycin, and tetracycline 
[27-30]. This is due to indiscriminate use of 
topical antibiotics [31,32]. Besides, Knobler’s 
study stated that patient’s inappropriate use of 
topical antibacterial drugs is one of the major 
factors in the development of bacterial resistance 
[12,32]. This again emphasized on the role and 
responsibilities of community pharmacists to 
counsel and educate patients in the correct 
usage of topical antibacterial drugs [31]. 
Moreover, Gollnick’s study stated that topical 
antibiotic should be used less often and for short 
duration only to avoid the development of 
resistances [33]. It can be replaced with 
combination of topical antibiotics with topical 
retinoid, with benzoyl peroxide ointment (BPO), 
or with azelaic acid because these combinations 
claim to reduce the resistance rate and at the 
same time enhance the efficacy of acne 
treatment [33]. This is further supported by 
Webster, author of Clinical Review of Acne 
Vulgaris, who said that use combination of 
clindamycin and benzoyl peroxide gel brings 
more benefits than using topical antibiotic alone. 
This review also mentioned that bacterial 
resistance happened more frequently with topical 
clindamycin and erythromycin. In addition, it is 
observed that combination of topical antibiotics 
with benzoyl peroxide is more useful than single 
topical antibiotics in the management of acne 
[34]. 
 
Lack of research on antibacterial resistance 
 
Topical antibacterial drug is one of the over-the-
counter products, but study specific to topical 
antibacterial drugs is lacking, and only little 
information about topical antibacterial drugs can 
be extracted from articles discussing OTC 
products. Besides, there are research articles 
which discussed about usage of antibiotics which 
includes both oral and topical antibiotics, but 
studies which only focus on topical antibiotics are 
limited even though several antibacterial agents 
have emerged over the years (Figure 1).  
 
A study conducted in United Kingdom showed 
that topical antibiotics were the most purchased 
OTC products. Not only as over the counter 
products, topical antibacterial drugs also appear 
to be the most often requested prescription only 
medications (POM), followed by antibiotic-steroid 
combinations [35]. In addition to that, an 
observational study carried out in England found 
that the sales of topical chloramphenicol, a type 
of topical antibiotic had increased to 47.8 % 
within three years (2005 - 2007) after the product 
was made available over the counter [36]. 
 
Furthermore, a study carried out by National 
Center for Health Statistic (NCHS) also showed 
that topical antibacterial drugs combinations such 
as bacitracin, polymyxin/bacitracin as well as 
neomycin/polymyxin/bacitracin were listed as top 
twenty over the counter products for all 
physicians. In spite of that, the usage of the 
topical antibacterial drugs combinations 
mentioned was varied between dermatologists 
and non-dermatologists with 14.9 and 12.2 % 
respectively [11]. Moreover, a study carried out in 
the United States of America (USA) showed that 
dermatologists generally prescribed topical 
antibacterial drugs for conditions such as 
localized cutaneous bacterial infections, infected 
eczema, acne vulgaris, staphylococcal nasal 
carriage, postoperative prophylaxis of wound  
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                                       Figure 1: Research status in antibiotic development [40] 
 





Most of the studies on the usage of topical 
antibacterial have as their target population 
general practitioners, physicians and 
dermatologists, but only few studies has 
assessed whole communities. Antibacterial 
resistance ratio is also silently growing without 
any comprehensive measurements. Moreover, 
the studies focused on doctors.  Based on the 
review evidence, hypothesis we are created and 
approached to convert the review hypothesis to 
research to ascertain the resistance occurrence 
of antibacterial utilization in Malaysia. Thus, 
further studies need to be conducted in Malaysia 
that specifically focus on community 
pharmacists. This is because available studies 
have not clearly pointed out the role of 
community pharmacists in dispensing, 
counselling, and educating the public on the 
usage of topical antibacterials; hence, this review 
hypothesis should test the community pharmacist 
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